U.S. Markets close in 2 hrs 7 mins

Boston Scientific received approval to update DFU labeling for Promus Element

Boston Scientific has received approval to update the directions for use, or DFU, labeling for Promus Element and Promus Element Plus Coronary Stent Systems to include three-month Dual Anti-Platelet Therapy, or DAPT. This language outlines a minimum duration of three months of DAPT for certain patients who may need to interrupt or discontinue the medication for a variety of reasons and supports the strong safety profile for Promus Element and Promus Element Plus Stents. The label change will be introduced in CE Mark countries.